THE STABILIZATION OF A HUMAN-IGM MONOCLONAL-ANTIBODY WITH POLY(VINYLPYRROLIDONE)

被引:49
|
作者
GOMBOTZ, WR
PANKEY, SC
PHAN, D
DRAGER, R
DONALDSON, K
ANTONSEN, KP
HOFFMAN, AS
RAFF, HV
机构
[1] BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,BIOL PROC RES,SEATTLE,WA 98121
[2] MILES INC,CUTTER BIOL,BERKELEY,CA 94701
[3] UNIV WASHINGTON,CTR BIOENGN FL 20,SEATTLE,WA 98195
关键词
PROTEIN STABILITY; PROTEIN AGGREGATION; MONOCLONAL ANTIBODIES; VOLUME EXCLUSION; POLY(VINYLPYRROLIDONE);
D O I
10.1023/A:1018903624373
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An IgM anti-group B Streptococcus monoclonal antibody (4B9) was found to undergo irreversible heat-induced aggregation at 50 degrees C. A variety of excipients was tested for their ability to inhibit antibody aggregation. The amount of 4B9 aggregation, which was determined by analysis on a size-exclusion HPLC, was significantly reduced in the presence of low concentrations [between 0.1 and 1.0% (w/v)] of poly(vinylpyrrolidone) (PVP) molecules ranging in molecular weight from 10 to 40 kDa. When the PVP concentration was greater than 1.05%, antibody aggregation was enhanced, and with the highest molecular weight PVP, antibody precipitation occurred. HPLC was used to show that more PVP was associated with the 4B9 at 50 degrees C than at 25 degrees C. Differential scanning calorimetry revealed that PVP concentrations greater than 2.0% decreased the antibody thermal transition temperature. Enzyme-linked immunosorbent assays were used to assess the effects of PVP on the antigen binding capacity of 4B9 and on 4B9 quantitation. At 4 degrees C, PVP solutions of up to 5.0% had no effect on either 4B9 quantitation or antigen binding. At 50 degrees C, however, less 4B9 was detected in the 5.0% PVP solution. The heat stabilization of the 4B9 antibody by low concentrations of PVP can be explained by a weak binding of PVP to the native protein. The PVP may sterically interfere with protein-protein interactions, thus reducing aggregation. Higher concentrations of PVP lead to protein aggregation and precipitation, probably by a volume-exclusion mechanism. Low concentrations of less than 1.0% PVP can be used to stabilize proteins against heat-induced aggregation, but care should be exercised, since even slightly higher concentrations of PVP can also lead to protein destabilization.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 50 条
  • [31] SINGLE-DOSE PHARMACOKINETICS AND SAFETY OF HA-1A, A HUMAN-IGM ANTI-LIPID-A MONOCLONAL-ANTIBODY, IN PEDIATRIC-PATIENTS WITH SEPSIS SYNDROME
    ROMANO, MJ
    KEARNS, GL
    KAPLAN, SL
    JACOBS, RF
    KILLIAN, A
    BRADLEY, JS
    MOSS, MM
    VANDYKE, R
    RODRIGUEZ, W
    STRAUBE, RC
    JOURNAL OF PEDIATRICS, 1993, 122 (06): : 974 - 981
  • [32] A HUMAN-IGM MONOCLONAL-ANTIBODY (MAB) AGAINST ENDOTOXIN (HA-1A) DECREASED SURVIVAL IN A CANINE MODEL OF GRAM-NEGATIVE BACTERIAL SEPTIC SHOCK
    QUEZADO, ZMN
    NATANSON, C
    BANKS, SM
    ALLING, DW
    KOEV, CA
    DANNER, RL
    ELIN, RJ
    HOSSEINI, JM
    POLLACK, M
    BACHER, JD
    DOLAN, DP
    HOFFMAN, WD
    CLINICAL RESEARCH, 1992, 40 (02): : A286 - A286
  • [33] BIODISTRIBUTION AND TUMOR-LOCALIZATION OF I-125 LABELED HUMAN-IGM MONOCLONAL-ANTIBODY COU-1 IN NUDE-MICE BEARING HUMAN TUMOR GRAFTS
    DITZEL, H
    RASMUSSEN, JW
    ERB, K
    BORUPCHRISTENSEN, P
    JENSENIUS, JC
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (04): : 507 - 515
  • [34] PHARMACOKINETICS OF AN IGM HUMAN MONOCLONAL-ANTIBODY AGAINST PSEUDOMONAS-AERUGINOSA IN NONSEPTIC PATIENTS
    MENG, YG
    WONG, T
    SARAVOLATZ, LD
    PENNINGTON, JE
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 784 - 785
  • [35] HUMAN-IGM ANTIBODY TO SULFAMETHOXAZOLE IN AN ADVERSE REACTION TO TRIMETHOPRIM-SULFAMETHOXAZOLE
    RESSLER, C
    KNAPP, MM
    TATAKE, JG
    BALLOW, M
    RAPACZ, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 198 - 198
  • [36] CLONING AND REEXPRESSION OF A FUNCTIONAL HUMAN-IGM ANTI-LIPID-A ANTIBODY
    DORAI, H
    BUBBERS, JE
    GILLIES, SD
    HYBRIDOMA, 1992, 11 (05): : 667 - 675
  • [37] HUMAN MONOCLONAL-ANTIBODY AGAINST HUMAN LYMPHOCYTIC CELLS - A HUMAN MONOCLONAL-ANTIBODY THAT REACTS PREFERENTIALLY WITH HUMAN LYMPHOCYTIC CELLS
    HARPPRECHT, J
    HANSMANN, ML
    WESTPHAL, E
    MULLERRUCHHOLTZ, W
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1988, 87 (04): : 400 - 404
  • [38] SPECIFICITY OF HUMAN-IGM MONOCLONAL-ANTIBODIES FROM PATIENTS WITH PERIPHERAL NEUROPATHY
    OSHANNESSY, DJ
    ILYAS, AA
    DALAKAS, MC
    MENDELL, JR
    QUARLES, RH
    JOURNAL OF NEUROIMMUNOLOGY, 1986, 11 (02) : 131 - 136
  • [39] MONOCLONAL-ANTIBODY TO HUMAN CARTILAGE CELLS
    CHEN, JC
    PREPOLEC, M
    PISTON, JC
    BERNSTEIN, J
    POULIK, MD
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 745 - 745
  • [40] LOCALIZATION OF GLIOMA BY HUMAN MONOCLONAL-ANTIBODY
    PHILLIPS, J
    SIKORA, K
    WATSON, JV
    LANCET, 1982, 2 (8309): : 1214 - 1215